- Home
- CVRX
CVRX
CVRx Inc.
as 12-18-2024 12:35pm EST
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 311.3M | IPO Year: | 2021 |
| Target Price: | $16.67 | AVG Volume (30 days): | 179.7K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.40 - $33.14 | Next Earning Date: | 01-23-2025 |
| Revenue: | $47,255,000 | Revenue Growth: | 34.38% |
| Revenue Growth (this year): | 31.78% | Revenue Growth (next year): | 26.42% |
Stock Insider Trading Activity of CVRx Inc. (CVRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VERRASTRO PAUL | CVRX | CHIEF MKTG & STRAT OFFICER | Nov 19 '24 | Sell | $13.58 | 1,430 | $19,416.68 | 1,875 |
Latest CVRx Inc. News
CVRX Breaking Stock News: Dive into CVRX Ticker-Specific Updates for Smart Investing
Insider Monkey
22 days ago
Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team
GlobeNewswire
a month ago
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire
a month ago
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
Simply Wall St.
2 months ago
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
GuruFocus.com
2 months ago
CVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses
Zacks
2 months ago
CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates
Associated Press Finance
2 months ago
CVRx: Q3 Earnings Snapshot
GlobeNewswire
2 months ago
CVRx Reports Third Quarter 2024 Financial and Operating Results
Compare CVRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVRX CVRx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.